Global Bordetella Vaccine for Dogs Market Growth 2023-2029

Global Bordetella Vaccine for Dogs Market Growth 2023-2029

The global Bordetella Vaccine for Dogs market size is projected to grow from US$ 293.5 million in 2022 to US$ 689 million in 2029; it is expected to grow at a CAGR of 13.0% from 2023 to 2029.

United States market for Bordetella Vaccine for Dogs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Bordetella Vaccine for Dogs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Bordetella Vaccine for Dogs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Bordetella Vaccine for Dogs players cover Boehringer Ingelheim(Merial), Merck Animal Health, Zoetis and Elanco, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Bordetella Vaccine for Dogs Industry Forecast” looks at past sales and reviews total world Bordetella Vaccine for Dogs sales in 2022, providing a comprehensive analysis by region and market sector of projected Bordetella Vaccine for Dogs sales for 2023 through 2029. With Bordetella Vaccine for Dogs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bordetella Vaccine for Dogs industry.

This Insight Report provides a comprehensive analysis of the global Bordetella Vaccine for Dogs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bordetella Vaccine for Dogs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bordetella Vaccine for Dogs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bordetella Vaccine for Dogs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bordetella Vaccine for Dogs.

This report presents a comprehensive overview, market shares, and growth opportunities of Bordetella Vaccine for Dogs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Intranasal Bordetella Vaccine
Oral Bordetella Vaccine
Injectable Bordetella Vaccine

Segmentation by application
Puppies
Adult Dogs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Elanco

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bordetella Vaccine for Dogs market?

What factors are driving Bordetella Vaccine for Dogs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bordetella Vaccine for Dogs market opportunities vary by end market size?

How does Bordetella Vaccine for Dogs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: the online download version of this report is for a global site license.